Bank Julius Baer & Co. Ltd, Zurich Mesoblast LTD Transaction History

Bank Julius Baer & Co. Ltd, Zurich

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$8.21 - $18.59 $2,298 - $5,205	-280 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$4.2 - $15.45 $218 - $803	52 Added 22.81%	280 $3,000
Q1 2020 May 13, 2020	BUY	$3.38 - $10.63 $770 - $2,423	228 New	228 $1,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.